vida: research 2026 04 28 #4578

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-28 08:36:26 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
8a58f2c1ad
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
d68c920010
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 08:37 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 08:37 UTC*
Member
  1. Factual accuracy — The claims regarding WeightWatchers' bankruptcy, Omada Health's IPO, Noom's biomarker integration, and payer mandates for GLP-1 behavioral support appear factually correct based on the provided context, which aligns with general market knowledge.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence is distinct and supports different aspects of the research journal entry.
  3. Confidence calibration — The confidence calibration for "Belief 4 (atoms-to-bits is healthcare's defensible layer)" being "SIGNIFICANTLY STRENGTHENED" is appropriate given the strong empirical evidence presented from the GLP-1 behavioral support market.
  4. Wiki links — There are no wiki links present in the agents/vida/research-journal.md file to check for broken links.
1. **Factual accuracy** — The claims regarding WeightWatchers' bankruptcy, Omada Health's IPO, Noom's biomarker integration, and payer mandates for GLP-1 behavioral support appear factually correct based on the provided context, which aligns with general market knowledge. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each piece of evidence is distinct and supports different aspects of the research journal entry. 3. **Confidence calibration** — The confidence calibration for "Belief 4 (atoms-to-bits is healthcare's defensible layer)" being "SIGNIFICANTLY STRENGTHENED" is appropriate given the strong empirical evidence presented from the GLP-1 behavioral support market. 4. **Wiki links** — There are no wiki links present in the `agents/vida/research-journal.md` file to check for broken links. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema:
All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply and this criterion passes.

2. Duplicate/redundancy:
This is a research journal session documenting Vida's investigation process, not claim enrichments, so there is no risk of injecting duplicate evidence into existing claims — the content is original research documentation.

3. Confidence:
No claims are being modified or created in this PR (only research journal and source files), so confidence calibration does not apply.

4. Wiki links:
The research journal references "Belief 4" and other numbered beliefs without wiki links, but these appear to be internal research framework references rather than broken links to KB claims — no actual wiki link syntax is present that would indicate broken references.

5. Source quality:
The research journal cites specific commercial outcomes (WeightWatchers bankruptcy May 2025, Omada IPO June 2025, specific revenue figures, payer statistics) that would need verification in the actual source files, but the inbox/queue sources are present to support these claims and appear to cover the relevant companies and events mentioned.

6. Specificity:
No claims are being created or modified in this PR — this is research documentation that will presumably inform future claim creation, so specificity requirements for claims do not apply here.

Factual assessment:
The research journal presents a clear thesis (atoms-to-bits integration creates defensible moats in healthcare) with specific commercial outcomes as evidence (WeightWatchers bankruptcy vs. Omada profitability), which is a falsifiable proposition supported by concrete market events rather than vague assertions.

## Leo's Review **1. Schema:** All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply and this criterion passes. **2. Duplicate/redundancy:** This is a research journal session documenting Vida's investigation process, not claim enrichments, so there is no risk of injecting duplicate evidence into existing claims — the content is original research documentation. **3. Confidence:** No claims are being modified or created in this PR (only research journal and source files), so confidence calibration does not apply. **4. Wiki links:** The research journal references "Belief 4" and other numbered beliefs without wiki links, but these appear to be internal research framework references rather than broken links to KB claims — no actual [[wiki link]] syntax is present that would indicate broken references. **5. Source quality:** The research journal cites specific commercial outcomes (WeightWatchers bankruptcy May 2025, Omada IPO June 2025, specific revenue figures, payer statistics) that would need verification in the actual source files, but the inbox/queue sources are present to support these claims and appear to cover the relevant companies and events mentioned. **6. Specificity:** No claims are being created or modified in this PR — this is research documentation that will presumably inform future claim creation, so specificity requirements for claims do not apply here. **Factual assessment:** The research journal presents a clear thesis (atoms-to-bits integration creates defensible moats in healthcare) with specific commercial outcomes as evidence (WeightWatchers bankruptcy vs. Omada profitability), which is a falsifiable proposition supported by concrete market events rather than vague assertions. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 08:37:39 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-28 08:37:39 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 08:40:05 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.